Email this article EFFICIENCY OF USING A COMBINATION OF AVASTIN AND LOW-DOSE INTERFERON-Α2A IN THE TREATMENT OF METASTATIC RENAL CELL CARCINOMA
- Authors: Alekseev B.Y.1, Kalpinsky A.S.1
-
Affiliations:
- P.A. Herzen Moscow Oncology Research Institute
- Issue: Vol 7, No 3 (2011)
- Pages: 70-74
- Section: DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. RENAL CANCER
- Published: 30.09.2011
- URL: https://oncourology.abvpress.ru/oncur/article/view/237
- DOI: https://doi.org/10.17650/1726-9776-2011-7-3-70-74
- ID: 237
Cite item
Full Text
Abstract
Due to the introduction of angiogenesis inhibitors into clinical practice to treat metastatic renal cell carcinoma, the trials dealing with the use of this class of medications are urgent. The paper gives the results of studies of the efficacy of bevacizumab in combination with low-dose interferon-α2a.
About the authors
B. Ya. Alekseev
P.A. Herzen Moscow Oncology Research Institute
Author for correspondence.
Email: byalekseev@mail.ru
Russian Federation
A. S. Kalpinsky
P.A. Herzen Moscow Oncology Research Institute
Email: byalekseev@mail.ru
Russian Federation
References
Supplementary files
